← Back to Patent Explorer
US4335102A Expired / Lapsed US ⏱️ 0.0 years remaining

Oral composition for caries prophylaxis

Assignee: Lion Corp
•
Filing: 1980-09-09
•
Granted: 1982-06-15
•
Expires: 2000-09-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An oral composition for caries prophylaxis which comprises a highly soluble stannous compound such as stannous fluoride preferably in an amount of 0.03 to 5% by weight of the composition as stannous tin, a difficultly soluble stannous compound such as stannous pyrophosphate preferably in an amount of 0.05 to 10% by weight of the composition as stannous tin, a phytic acid compound such as sodium phytate preferably in an amount of 0.1 to 20% by weight of the composition, and the pH of the composition being preferably acidic. A portion of the difficultly soluble stannous compound may be in a precipitate form. The oral composition which may be used as dentifrices, prophylactic pastes, dental flosses and the like permits n 2+ ions to exert its effect because the storage stability is high enough to maintain the increased concentration of active dissolved stannous ions in the composition for a prolonged period of time and can render the tooth enamel more resistant to acid attack when applied to teeth.

Inventors

  • 👤 Syozi Nakashima
  • 👤 Tosiyuki Ozawa
  • 👤 Takeshi Naganuma
  • 👤 Takashi Ujiie
  • 👤 Satoshi Hayashi
  • 👤 Yoshihito Ochiai

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 20:13
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/19; A61K8/20; A61K8/21; A61K8/24; A61K8/30; A61K8/55; A61Q; A61Q11/00

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 161 words
An oral composition for caries prophylaxis, comprising: a highly soluble stannous compound selected from the group consisting of stannous fluoride, stannous chloride, stannous chloride fluoride, sodium stannous fluoride, potassium stannous fluoride, stannous acetate, stannous hexafluorozirconate, stannous sulfate, stannous tartrate, stannous gluconate and mixtures thereof, said highly soluble stannous compound being present in the range of 0.03% to 5% by weight of the composition as stannous tin; a difficulty soluble stannous compound selected from the group consisting of stannous pyrophosphate, stannous metaphosphate, stannous oxide, stannous oxalate, stannous phosphate and mixtures thereof, said difficulty soluble stannous compound being present in the range of 0.05% to 10% by weight of the composition as stannous tin; and 0.1% to 20% by weight of the composition of a phytic acid compound selected from the group consisting of phytic acid, sodium phytate, potassium phytate, lithium phytate, ammonium phytate, magnesium phytate, zinc phytate, calcium phytate, aluminum phytate, phytin, double salts thereof and mixtures thereof, said composition being acidic.
Claim 2
Dependent Claim 161 words
An oral composition for caries prophylaxis, comprising: a highly soluble stannous compound selected from the group consisting of stannous fluoride, stannous chloride, stannous chloride fluoride, sodium stannous fluoride, potassium stannous fluoride, stannous acetate, stannous hexafluorozirconate, stannous sulfate, stannous tartrate, stannous gluconate and mixtures thereof, said highly soluble stannous compound being present in the range of 0.03% to 5% by weight of the composition as stannous tin; a difficulty soluble stannous compound selected from the group consisting of stannous pyrophosphate, stannous metaphosphate, stannous oxide, stannous oxalate, stannous phosphate and mixtures thereof, said difficulty soluble stannous compound being present in the range of 0.05% to 10% by weight of the composition as stannous tin; and 0.1% to 20% by weight of the composition of a phytic acid compound selected from the group consisting of phytic acid, sodium phytate, potassium phytate, lithium phytate, ammonium phytate, magnesium phytate, zinc phytate, calcium phytate, aluminum phytate, phytin, double salts thereof and mixtures thereof, said composition being acidic.
Claim 3
Dependent Claim 21 words
The oral composition according to claim 1, wherein a portion of the difficulty soluble stannous compound is in a precipitate form.
Claim 4
Dependent Claim 49 words
The oral composition according to claim 1, wherein the highly soluble stannous compound is stannous fluoride in an amount of 0.08 to 3% by weight of the composition, and the difficultly soluble stannous compound is stannous pyrophosphate in an amount of 0.1 to 3% by weight of the composition.
Claim 5
Dependent Claim 26 words
The oral composition according to claim 1, wherein the phytic acid compound is present in an amount of 0.5 to 5% by weight of the composition.
Claim 6
Dependent Claim 39 words
The oral composition according to claim 1, wherein said phytic acid compound is selected from the group consisting of phytic acid, sodium phytate, potassium phytate, lithium phytate, ammonium phytate, magnesium phytate, calcium phytate, double salts thereof and mixtures thereof.
Claim 7
Dependent Claim 15 words
The oral composition according to claim 1 or 2 in the form of a toothpaste.
Claim 8
Dependent Claim 16 words
The oral composition according to claim 1 or 2, in the form of a liquid mouthwash.
Claim 9
Dependent Claim 16 words
The oral composition according to claim 1 or 2, in the form of a mouthwash tablet.
Claim 10
Dependent Claim 16 words
The oral composition according to claim 1 or 2, in the form of a disintegratable tablet.
Claim 11
Dependent Claim 15 words
The oral composition according to claim 1 or 2, in the form of oral bands.
Claim 12
Dependent Claim 15 words
The oral composition according to claim 1 or 2, in the form of topical solutions.
Claim 13
Dependent Claim 16 words
The oral composition according to claim 1 or 2, in the form of a topical paste.
Claim 14
Dependent Claim 63 words
The oral composition according to claim 1 or 2, wherein a fluorine compound selected from the group consisting of sodium fluoride, potassium fluoride, lithium fluoride, ammonium fluoride, sodium monofluorophosphate, sodium hydrogen monofluorophosphate, potassium monofluorophosphate, ammonium monofluorophosphate, potassium hexafluorotitanate, potassium hexafluorozirconate and mixtures thereof is present in the composition in an amount capable of supplying 50 to 10,000 parts per million of fluorine ions.
Claim 15
Dependent Claim 29 words
The oral composition according to claim 13, wherein said fluorine compound is present in the composition in an amount capable of supplying 20-10,000 parts per million of fluorine ion.
Claim 16
Dependent Claim 19 words
The oral composition according to claim 1 or 2, wherein the composition has a pH of 2 to 7.
Claim 17
Dependent Claim 14 words
The oral composition according to claim 15, wherein the pH is 3 to 6.

References Cited (Backward Citations)

GB804486A Cited
GB845611A Cited
US2946725A Cited
US3105798A Cited
US3282792A Cited
GB1160640A Cited
US3549677A Cited
GB1222197A Cited
US3544678A Cited
GB1384375A Cited
GB1408922A Cited
US3934002A Cited
US4259316A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-06-14 1985-12-14 1986-06-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-06-14 1989-12-14 1990-06-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-06-14 1993-12-14 1994-06-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag